These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

542 related items for PubMed ID: 8792058

  • 1. Pharmacokinetic optimisation in the treatment of Parkinson's disease.
    Contin M, Riva R, Albani F, Baruzzi A.
    Clin Pharmacokinet; 1996 Jun; 30(6):463-81. PubMed ID: 8792058
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Clinical pharmacokinetic and pharmacodynamic properties of drugs used in the treatment of Parkinson's disease.
    Deleu D, Northway MG, Hanssens Y.
    Clin Pharmacokinet; 2002 Jun; 41(4):261-309. PubMed ID: 11978145
    [Abstract] [Full Text] [Related]

  • 4. Concentration-effect relationship of levodopa in patients with Parkinson's disease.
    Harder S, Baas H, Rietbrock S.
    Clin Pharmacokinet; 1995 Oct; 29(4):243-56. PubMed ID: 8549026
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Optimisation of treatment of Parkinson's disease with levodopa].
    Białecka M, Adamiak U, Gawrońska-Szklarz B.
    Neurol Neurochir Pol; 2009 Oct; 43(5):446-59. PubMed ID: 20054747
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Current management of motor fluctuations in patients with advanced Parkinson's disease treated chronically with levodopa.
    Melamed E, Zoldan J, Galili-Mosberg R, Ziv I, Djaldetti R.
    J Neural Transm Suppl; 1999 Oct; 56():173-83. PubMed ID: 10370911
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The pharmacokinetics and pharmacodynamics of levodopa in the treatment of Parkinson's disease.
    Khor SP, Hsu A.
    Curr Clin Pharmacol; 2007 Sep; 2(3):234-43. PubMed ID: 18690870
    [Abstract] [Full Text] [Related]

  • 13. Improving the Delivery of Levodopa in Parkinson's Disease: A Review of Approved and Emerging Therapies.
    Urso D, Chaudhuri KR, Qamar MA, Jenner P.
    CNS Drugs; 2020 Nov; 34(11):1149-1163. PubMed ID: 33146817
    [Abstract] [Full Text] [Related]

  • 14. Pharmacokinetic considerations for the use of levodopa in the treatment of Parkinson disease: focus on levodopa/carbidopa/entacapone for treatment of levodopa-associated motor complications.
    Müller T.
    Clin Neuropharmacol; 2013 Nov; 36(3):84-91. PubMed ID: 23673910
    [Abstract] [Full Text] [Related]

  • 15. Recent developments in the pharmacological treatment of Parkinson's disease.
    Tuite P, Riss J.
    Expert Opin Investig Drugs; 2003 Aug; 12(8):1335-52. PubMed ID: 12882620
    [Abstract] [Full Text] [Related]

  • 16. Pharmacodynamic and pharmacokinetic features of cabergoline. Rationale for use in Parkinson's disease.
    Fariello RG.
    Drugs; 1998 Aug; 55 Suppl 1():10-6. PubMed ID: 9483165
    [Abstract] [Full Text] [Related]

  • 17. Ropinirole therapy for Parkinson's disease.
    Pahwa R, Lyons KE, Hauser RA.
    Expert Rev Neurother; 2004 Jul; 4(4):581-8. PubMed ID: 15853577
    [Abstract] [Full Text] [Related]

  • 18. Pharmacokinetic-pharmacodynamic relationships of apomorphine in patients with Parkinson's disease.
    Neef C, van Laar T.
    Clin Pharmacokinet; 1999 Sep; 37(3):257-71. PubMed ID: 10511920
    [Abstract] [Full Text] [Related]

  • 19. Therapeutic drug monitoring in Parkinson's disease.
    Müller T, Gerlach M, Hefner G, Hiemke C, Jost WH, Riederer P.
    J Neural Transm (Vienna); 2024 Oct; 131(10):1247-1262. PubMed ID: 39227478
    [Abstract] [Full Text] [Related]

  • 20. Role of integrative pharmacokinetic and pharmacodynamic optimization strategy in the management of Parkinson"s disease patients experiencing motor fluctuations with levodopa.
    Okereke CS.
    J Pharm Pharm Sci; 2002 Oct; 5(2):146-61. PubMed ID: 12207867
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.